Notizie

Più notizie

  • 04.12.2023

    UBP London’s ambitious Nature Calls conference draws a crowd

    We recently held our first biodiversity conference in London, titled ‘Nature Calls!’ featuring a varied batch of panellists who led inspiring keynote speeches and discussions.

  • 29.11.2023

    Fixed income 2024: investment grade offers attractive risk-return

    Yields on investment-grade bonds are at levels not seen since the GFC, propelled by an inflation wave that caught central banks off guard, forcing them to make the fastest set of rate-hikes since the 1980s.

  • 28.11.2023

    Bell’s small & mid-cap portfolio – a bellwether

    Today, global SMID caps might represent one of the last areas within equities where the balance between fundamentals and valuations has been largely preserved.

  • 21.11.2023

    European real estate: capitalising on market dislocations

    The real estate market has had its share of upheavals and is in flux as Europe’s economies battle with the consequences of rising inflation and interest rates, weakening demand, and contracting exports, not to mention the unrest in Eastern Europe and the Middle East. Meanwhile real estate has its place as a value creator in investors’ portfolios.

  • 08.11.2023

    Global equities: time in the market rather than timing the market

    With a rebound in EPS growth expected for 2024, though with disparities between market segments, and with interest rates and inflation still at elevated levels, active management is key.

  • 30.10.2023

    Building an efficient equity portfolio of global leaders today

    Research has shown that 30 stocks is enough for a portfolio to efficiently diversify risks – and this without even taking into account the added benefits of active stock selection.

  • 13.10.2023

    Assessing positive impact in pharmaceuticals

    Pharma is a complex and fast-changing industry that plays a vital role in improving health outcomes and global access to medicines.

Our latest podcasts

Our latest podcasts

Iscrivetevi alle nostre newsletter